1417. Evaluating the Dissonance Between Cmax and AUC with Clinically Utilized Aminoglycoside (AG) Dosing Regimens: Use of Tobramycin (TOB) Against Pseudomonas aeruginosa (PA) as a Case Study | Zendy

AI Assistant Blog Pricing

1417. Evaluating the Dissonance Between Cmax and AUC with Clinically Utilized Aminoglycoside (AG) Dosing Regimens: Use of Tobramycin (TOB) Against Pseudomonas aeruginosa (PA) as a Case Study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.